ArticleClinical ophthalmology (Auckland, N.Z.)2025
Translation and Preliminary Validation of the Computer Vision Syndrome Scale-17 (CVSS-17) into Arabic: A Pilot Study.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To create and validate a culturally appropriate Arabic translation of the Computer Vision Syndrome Scale-17 (CVSS-17) for assessing computer vision syndrome (CVS) symptoms among Arabic-speaking populations. Patients and Methods: Following established cross-cultural adaptation guidelines, the CVSS-17 was translated into Arabic by two independent translators, then reviewed by an interdisciplinary committee and back-translated. The questionnaire was administered to 60 healthy Arabic-speaking participants (aged 18-40 years) across 2 sessions conducted 2-5 days apart. The psychometric evaluation included internal consistency and test-retest reliability. Results: The participants had an average age of 20.7 ± 1.3 years (45% male, 55% female), with mean CVSS-17 scores of 34.4 ± 11.0 (range: 20-60). The Arabic CVSS-17 demonstrated excellent internal consistency (Cronbach's α = 0.904, range: 0.890-0.905) and test-retest reliability ranging from 0.50-0.93, and item-retest correlations ranging from 0.57-0.91 (p < 0.001). The floor and ceiling effects were minimal (1.7% each), indicating good discriminative ability. Conclusion: The Arabic CVSS-17 demonstrated excellent reliability and internal consistency, highlighting its utility as a culturally appropriate screening tool for CVS symptoms in Arabic-speaking populations. The cultural adaptation of this questionnaire successfully maintains psychometric integrity and establishes a solid foundation for standardized CVS assessment research in Arabic-speaking regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.